Concept: Isocitrate dehydrogenase

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial

IDH1 inhibitor shows disease control in hard-to-treat cartilage tumors